A Multi-centre, Retrospective study to evaluate the safety and efficacy of Sunitinib in patients with Advanced Radioiodine Refractory Thyroid Carcinoma
Latest Information Update: 19 Feb 2018
At a glance
- Drugs Sunitinib (Primary)
- Indications Thyroid cancer
- Focus Therapeutic Use
- 19 Feb 2018 New trial record